for predicting outcomes in patients with acute decompensated heart failure. BNP measurements (recorded within 24 h of presentation) were available for 48,629 (63%) of the 77,467 hospitalization ...

It is hypothesized that intravenous milrinone, by producing biventricular afterload reduction, offers an efficacious, cost-effective tool for the treatment of decompensated heart failure.

Results Presented at CSI Focus D-HF Meeting Show Safe, Rapid Fluid and Sodium Removal, Highlighting Potential New Approach to Manage Acute Decompensated Heart Failure-- MILFORD, Mass.